Abstract X-Linked retinitis pigmentosa is a most severe and heterogeneous disorder of the retina. Recently, genes (RP2 and RPGR) from two X-linked loci have been positionally cloned and mutations have been identified in many families. To further evaluate allelic and non-allelic heterogeneity and the genotype -phenotype relationships, and to determine the prevalence of mutations in the gene, we have analyzed one previously unreported X-linked retinitis pigmentosa family, using a combination of haplotype analysis and DNA sequencing. Our extensive analysis of the RP2 gene failed to detect any disease -causing or polymorphic mutations. In the case of the RP3 gene, the alleles of the dinucleotide repeat marker did not segregate with the disease. Although we cannot completely exclude the possibility of the RP2 and RP3 genes as candidate genes, the above results suggest that structural and functional changes associated with the RP2 gene are not responsible for the phenotype in the family analyzed. Further identification of the X-linked genes may facilitate the elucidation of the molecular basis of the disorder in the family analyzed.
Introduction
Retinitis pigmentosa (RP) is a group of progressive retinal disorders with autosomal dominant, recessive, and X-linked forms. Of these, the X-linked disorder (XLRP) has consistently been shown to be the most severe type, and affected males manifest an early onset of the disorder with severe myopia. RP is characterized by a loss of the peripheral visual field, and night blindness (Bird 1975) . The disease affects both eyes, and the loss of central vision does not usually occur until age 50, although in some X-linked pedigrees, it may occur much earlier. When the disease progresses, loss of central vision occurs with degeneration of the retina, which leads to complete loss of sight. Carrier females usually have normal vision and a normal fundus. More than 25 loci have been mapped by linkage analysis, and, among these, at least two loci for XLRP have been identified on the short arm of the X-chromosome (Teague et al. 1994) . These are termed RP2 and RP3. Recently, genes (RP2 and RPGR) from these two X-linked loci have been positionally cloned (Meindl et al. 1996; Schwahn et al. 1998) and mutations have been identified in many families. To further evaluate allelic and non-allelic heterogeneity, and to establish a relationship between genotype and phenotype, we have analyzed one previously unreported XLRP family for mutations in the RP2 and RP3 genes.
Subjects and methods
The pedigree used in this study is shown in Fig. 1A and was described previously . All patients were informed of the purpose of the study, which was approved by the Institutional Review Board of Oakland University. Venous blood was collected from several affected and unaffected individuals, and high molecular-weight DNA was extracted as described before . For the purpose of DNA analysis, all five exons of the RP2 gene were amplified by the polymerase chain reaction (PCR), using commercially synthesized primers (Schwahn et al. 1998 ) spanning the splice sites. The PCR products were purified and directly sequenced using a cycle sequencing kit (Applied Biosystems, Foster City, CA, USA), according to the manufacturer's instructions. All samples were sequenced on both strands, using the same primers as for the PCR.
Results
The kindred shown in Fig. 1 has a history of RP. The clinical details (including electroretinography [ERG] , visual acuity, and field data) of the family were described previously .The proband has a pigmentary retinopathy similar to RP and high myopia. He has no other medical problems. Interestingly, however, all affected family members exhibited loss of central vision, in contrast to peripheral vision, at the age of 10-12 years. This suggests an unusual, severe cone -rod dystrophy in the family. In the pedigree, there are no male-to-male transmissions; all affected individuals are males and the transmission is from affected man to carrier daughter, to affected grandson, all consistent with an X-linked pattern of inheritance. In order to localize the disease gene and to categorize this XLRP kindred as being an RP2 or RP3 subtype, we first carried out haplotype analysis of markers close to the RP2 and RP3 candidate gene loci. A total of 11 microsatellite markers (DXS 228; DXS 1110; DXS 7; MAOA-3; DXS 426; DXS 453; DXY S1X; DXS 3; DXS 454; DXS 425; and DXS 292) spanning the entire X-chromosome have been analyzed. The results shown in Fig. 1B suggest that DXS 426 marker alleles could be followed and there was segregation of the DXS 426 locus with the disease. Because this marker has previously been shown to be linked to the RP2 type disorder (Coleman et al. 1990) , and because several other Xp, as well as Xq markers, could not be followed with the disease, the above results are indicative of evidence for an RP2 subtype disorder in this family. Unfortunately, further linkage analysis could not be undertaken because additional affected and unaffected family members declined to be tested. We next screened the genomic DNA from the proband and other available family members for mutations in the RP2 gene. Our extensive sequence analysis of all five exons (Fig. 2) revealed a wild-type sequence in the entire coding region, as well as splice sites of the RP2 gene. Although we cannot completely rule out the RP2 gene as a candidate gene in the present study (mutations in the upstream promoter or intronic sequence may be implicated), it appears unlikely that the RP2 type pathology in the family is caused by sequence variations in the coding region and splice sites of the RP2 gene.
Discussion
RP exhibits exceptional genetic and clinical heterogeneity. In XLRP, it has been suggested that RP2 and RP3 represent the two predominant forms (Teague et al. 1994) . Mutational analysis of the RPGR and RP2 genes together accounted for approximately 30% of familial XLRP cases (Hardcastle et al. 1999; Mears et al. 1999 ) mapped to these genetic loci. This still leaves about 70% of cases unaccounted for. One possible explanation is that the above results could be due to microheterogeneity around the RP2 and RP3 loci. This possibility is supported by the recent identification of additional XLRP loci (Mears et al. 1999) . Our extensive sequence analysis of one RP2 family also failed to detect any mutations in the RP2 gene, suggesting again that the RP2 gene is not the major gene responsible for the RP2 subtype disorder. These results provide additional support (RP2) is shown. The alleles produced by the PCR at the DXS 426 locus can be followed, and it can be seen that the RP syndrome appears to be transmitted with the b allele. The numbers 1-5 on the top of the lanes correspond to the numbers 1-5 in the pedigree. Although the differences in the intensity of bands in lane MGM could be due to the differential amplification of the two alleles, the reason for this difference in intensity is not known. PGM, Paternal grandmother; MGM, maternal grandmother for microheterogeneity around the RP2 locus, and will be helpful in establishing a relationship between the genotype and phenotype. In the future, identification of the gene responsible for the disorder may provide significant insight into the molecular basis of the disorder in this family. Meanwhile, contributions from genetic studies of other RP families will enrich our understanding of the molecular basis of several subtypes of this complex disorder.
